YARDLEY, PA — Optinose (NASDAQ: OPTN) is slated to share a comprehensive company overview at the H.C. Wainwright 2nd Annual BioConnect Investor Conference on May 20, 2024, at 11:30 a.m. ET.
“We are eager to present our strategic progress,” expressed an Optinose representative. To tune into the live webcast, interested individuals can visit Optinose’s Investors page.
Following the conference, a replay of the webcast will be accessible for 30 days. This event offers investors and stakeholders an invaluable opportunity to gain insights into Optinose’s recent developments and future plans, shaping discussions around the company’s trajectory in the healthcare industry.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.